Biotechnology Today
more-
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in mice
Many cancer-related proteins are considered “undruggable” because they’re chemically challenging for a drug to directly…
Regulus picks another horse in kidney disease in latest attempt to get pipeline back on track
Cochlear secures 2 FDA nods for telehealth method to program hearing implants from afar
Dexcom plots course to bring real-time blood glucose data to Garmin fitness devices
Withings goes head-to-head with Apple, nabbing FDA OK for smartwatch to detect afib, sleep apnea
Markets
more-
Weekly Market Review – October 16, 2021
Stock Markets As has been the dominant strategy throughout 2021, investors acted according to the…
Bio Space
more
Takeda bets up to $900M on Immusoft’s cell therapies for neurometabolic disorders
Immusoft has inked its first Big Pharma collaboration in a…
Olympus investigating ‘potential cybersecurity incident’ on American IT systems, its 2nd in a month
Olympus is investigating a possible cyberattack on its IT systems…
Charles River offloads Japanese research model site, Swedish gene therapy CDMO for $115M
Charles River Laboratories is parting ways with two divisions for…
Global News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in mice
Regulus picks another horse in kidney disease in latest attempt to get pipeline back on track
Cochlear secures 2 FDA nods for telehealth method to program hearing implants from afar
Dexcom plots course to bring real-time blood glucose data to Garmin fitness devices
Takeda bets up to $900M on Immusoft’s cell therapies for neurometabolic disorders
Olympus investigating ‘potential cybersecurity incident’ on American IT systems, its 2nd in a month
Charles River offloads Japanese research model site, Swedish gene therapy CDMO for $115M
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Withings goes head-to-head with Apple, nabbing FDA OK for smartwatch to detect afib, sleep apnea
Mayo Clinic taps Personalis for genome sequencing to guide cancer therapy and R&D